GIGYF1, which is associated with Autism Spectrum Disorder (ASD) and indirectly linked to AD, as well as ADAMTSL4, involved in the metabolism of amyloidogenic peptides in AD, were both down-regulated in ACD patients. Here, ADAMTSL4 is linked to granular corneal dystrophy type II.